Moderato System in Patients With Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 203 participants.

Also called NCT03757377

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 203 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03757377
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Lithuania, Poland (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT03757377. Randomized; double masking; primary purpose treatment. Start 2017-08-30 (actual); primary completion 2021-05-13 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Moderato System in Patients With Hypertension
Condition
Hypertension, Resistant to Conventional Therapy
Condition
Atrioventricular Block
Intervention (Device)
BackBeat Moderato System
Intervention (Device)
BackBeat Moderato Sytsem
Lead sponsor
BackBeat Medical Inc (class: industry)
Collaborator
Massachusetts General Hospital (class: other)
Collaborator
MLM Medical Labs GmbH (class: industry)
Collaborator
nabios GmbH (class: not stated)

Record details

Record id
cardio:ct-nct03757377
Content hash
1c6926e68a113d081447e4b8d4a72c4235ee6bae47e7913beb15592970ff3571